Cite

HARVARD Citation

    Tovoli, F. et al. (n.d.). Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma: efficacy, safety and prognostic factors. Digestive and liver disease. pp. S10-. [Online]. 
  
Back to record